Results 41 to 50 of about 4,213 (222)

Proton Radiotherapy for Vestibular Schwannomas in Patients with NF2-Related Schwannomatosis: A Case Series

Current Oncology, 2023
(1) Background: This study aimed to evaluate the efficacy and treatment-related toxicity of proton radiotherapy (PRT) for vestibular schwannoma (VS) in patients with neurofibromatosis type 2-related schwannomatosis (NF2).
Jules P. J. Douwes, Kimberley S. Koetsier, Victor S. van Dam, Scott R. Plotkin, Frederick G. Barker, D. Bradley Welling, Jeroen C. Jansen, Erik F. Hensen, Helen A. Shih   +8 more
doaj   +1 more source

A rare case of spinal schwannomatosis presenting as conus-cauda syndrome

Journal of Spinal Surgery, 2016
Multiple extra cranial schwannomas are generally associated with neurofibromatosis (NF) syndromes. Presence of multicentric schwannomas in absence of NF2 is a very rare entity.
Sharadendu Narayan, Nilesh Jain, Harshad Patil   +2 more
doaj   +1 more source

Spatial Distribution and Long-Term Alterations of Peripheral Nerve Lesions in Schwannomatosis

Diagnostics, 2022
Purpose To examine the spatial distribution and long-term alterations of peripheral nerve lesions in patients with schwannomatosis by in vivo high-resolution magnetic resonance neurography (MRN).
Tim Godel, Philipp Bäumer, Said Farschtschi, Barbara Hofstadler, Sabine Heiland, Mathias Gelderblom, Martin Bendszus, Victor-Felix Mautner   +7 more
doaj   +1 more source

Recurrent schwannomatosis with mosaic SMARCB1 loss: A case report. [PDF]

Exp Ther Med
Schwannomatosis is a non-cancerous disorder causing peripheral nerve sheath tumors (schwannomas), often leading to chronic pain. It is linked to loss of SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily B member 1 ...
Lakhina Y, Lim MA, Yonk MG, Campbell M, Tora MS, Du Y, Koshkin S, Lei K, Boulis NM.   +8 more
europepmc   +2 more sources

Neurofibromatosis 2011: a report of the Children’s Tumor Foundation Annual Meeting [PDF]

, 2011
The 2011 annual meeting of the Children\u27s Tumor Foundation, the annual gathering of the neurofibromatosis (NF) research and clinical communities, was attended by 330 participants who discussed integration of new signaling pathways into NF research ...
Alison C. Lloyd, Anat Stemmer-Rachamimov, C. Oliver Hanemann, D. Gareth Evans, David Ingram, David Viskochil, Debra A. Mayes, Duojia Pan, Dusica Babovic-Vuksanovic, Filippo Giancotti, Helen Morrison, Karen Cichowski, Kathryn North, Kim Hunter-Schaedle, Ludwine Messiaen, Margret R. Wallace, Maria T. Acosta, Meena Upadhyaya, Michel Kalamarides, Nancy Ratner, Olli Carpen, Roger Packer   +21 more
core   +3 more sources

Integrative analysis identifies candidate tumor microenvironment and intracellular signaling pathways that define tumor heterogeneity in NF1 [PDF]

, 2020
Neurofibromatosis type 1 (NF1) is a monogenic syndrome that gives rise to numerous symptoms including cognitive impairment, skeletal abnormalities, and growth of benign nerve sheath tumors.
Allaway, Robert J, Baker, Aaron, Banerjee, Jineta, Blakeley, Jaishri O, Gosline, Sara Jc, Greene, Casey S, Guinney, Justin, Hirbe, Angela, Moon, Chang In, Pratilas, Christine A, Taroni, Jaclyn N, Zhang, Xiaochun   +11 more
core   +2 more sources

Neurocognitive outcomes in neurofibromatosis clinical trials [PDF]

, 2016
Neurofibromatosis type 1 (NF1) is associated with neurocognitive deficits that can impact everyday functioning of children, adolescents, and adults with this disease.
de Blank, P, Gray, LS, Hanemann, CO, Hardy, KK, Janusz, J, Klein-Tasman, BP, Martin, S, Payne, JM, Semerjian, C, Solomon, SE, Thompson, HL, Toledo-Tamula, MA, Ullrich, N, Walsh, KS, Wolters, PL   +14 more
core   +2 more sources

The Molecular Pathogenesis, Diagnostic Criteria, Symptoms, Clinical Manifestations, and Gene-Based Therapeutic Approaches in Neurofibromatosis [PDF]

مجله دانشگاه علوم پزشکی گرگان, 2023
Neurofibromatosis (NF) is a heterogeneous group of tumor predisposition syndromes that lead to malignancy in the central and peripheral nervous systems.
Fatemeh Shahraki, Morteza Oladnabi
doaj  

PTPN11 mutation manifesting as LEOPARD syndrome associated with hypertrophic plexi and neuropathic pain. [PDF]

, 2015
BACKGROUND: LEOPARD syndrome (LS) belongs to the family of neuro-cardio-facio-cutaneous syndromes, which include Neurofibromatosis-1 (NF1), Noonan syndrome, Costello Syndrome, cardio-facio-cutaneous syndrome, Noonan-like syndrome with loose anagen hair ...
Croquelois, A., Kuntzer, T., Spatola, M., Wider, C.   +3 more
core   +1 more source

Recurrent orbital schwannomas: clinical course and histopathologic correlation

BMC Ophthalmology, 2012
Background Schwannomas are slow-growing typically encapsulated tumors composed of differentiated Schwann cells, the primary class of peripheral glial cells.
Kron Michelle, Bohnsack Brenda L, Archer Steven M, McHugh Jonathan B, Kahana Alon   +4 more
doaj   +1 more source